We are live on ! Find out more
OSTX

OS Therapies Inc

25 hedge funds and large institutions have $2.49M invested in OS Therapies Inc in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

0.1% more ownership

Funds ownership: 4.94%5.04% (+0.1%)

0% more funds holding

Funds holding: 2525 (0)

19% less capital invested

Capital invested by funds: $3.07M → $2.49M (-$580K)

Holders
25
Holders Change
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
8
Reduced
4
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
GSC
26
Ground Swell Capital
South Carolina
-$40.1K -20,462 Closed
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
-$29.3K -14,961 Closed
SMH
28
Sanders Morris Harris
Texas
-$23.5K -12,000 Closed
TSS
29
Two Sigma Securities
New York
-$20.1K -10,237 Closed
JP Morgan Chase
30
JP Morgan Chase
New York
-$25 -13 Closed
FIA
31
FNY Investment Advisers
New York
+$180 +100 New

OSTX Hedge Fund Activity: Q4 2025 in Review

25 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in OS Therapies Inc (OSTX) for Q4 2025, worth a combined $2.49M — down 19% from $3.07M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new OSTX positions and 6 closed out — a net gain of 1 holder — while 8 added to existing stakes and 4 trimmed.

The largest buyer was Vanguard Group, adding an estimated $635K. The largest seller was Marshall Wace, cutting an estimated $160K.

  • 25 institutional investors held OS Therapies Inc (OSTX) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $2.49M of OS Therapies Inc stock for Q4 2025, down 19% quarter-over-quarter.
  • 7 funds opened new OS Therapies Inc positions in Q4 2025 and 6 closed out, a net change of +1 holder.
  • The largest OS Therapies Inc buyer in Q4 2025 was Vanguard Group, an estimated $635K added.
  • The largest OS Therapies Inc seller in Q4 2025 was Marshall Wace, an estimated $160K sold.

Based on aggregated 13F filings for Q4 2025.